(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/04/22 | 日証協 | 420,200株 | +9.91% | 99,200株 | -32.93% | 253,947株 | +9.47% | 39,351株 | -27.57% |
2016/04/15 | 日証協 | 382,300株 | -36.22% | 147,900株 | -22.16% | 231,972株 | -39.13% | 54,331株 | -64.77% |
2016/04/08 | 日証協 | 599,390株 | +33.38% | 190,000株 | -0.96% | 381,118株 | +44.03% | 154,231株 | +114.47% |
2016/04/01 | 日証協 | 449,390株 | +6.69% | 191,838株 | +217.61% | 264,603株 | -3.99% | 71,913株 | +280.29% |
2016/03/25 | 日証協 | 421,200株 | +9.03% | 60,400株 | +0.83% | 275,593株 | -2.03% | 18,910株 | -67.03% |
2016/03/18 | 日証協 | 386,300株 | +6.77% | 59,900株 | -0.99% | 281,305株 | +6.09% | 57,352株 | +29.76% |
2016/03/11 | 日証協 | 361,800株 | +13.13% | 60,500株 | +2.72% | 265,153株 | +3.35% | 44,200株 | +68.9% |
2016/03/04 | 日証協 | 319,800株 | +12.45% | 58,900株 | -7.54% | 256,553株 | +3.96% | 26,170株 | -52.77% |
2016/02/26 | 日証協 | 284,400株 | -7.63% | 63,700株 | -60.94% | 246,773株 | +3.57% | 55,410株 | -33.74% |
2016/02/19 | 日証協 | 307,900株 | +28.72% | 163,100株 | +53% | 238,258株 | +20.36% | 83,620株 | +281.83% |
2016/02/12 | 日証協 | 239,200株 | -6.96% | 106,600株 | +294.81% | 197,953株 | -5.58% | 21,900株 | -15.44% |
2016/02/05 | 日証協 | 257,100株 | +51.77% | 27,000株 | -70.36% | 209,653株 | +27.41% | 25,900株 | -16.99% |
2016/01/29 | 日証協 | 169,400株 | -55.46% | 91,100株 | +66.85% | 164,553株 | -44.19% | 31,200株 | -6.02% |
2016/01/22 | 日証協 | 380,300株 | +5.11% | 54,600株 | +8.12% | 294,853株 | +18.68% | 33,200株 | -52.84% |
2016/01/15 | 日証協 | 361,800株 | +7.17% | 50,500株 | -51.81% | 248,453株 | +8.42% | 70,400株 | +437.36% |
2016/01/08 | 日証協 | 337,600株 | +65.33% | 104,800株 | +1996% | 229,153株 | +69.53% | 13,101株 | +43.97% |
2015/12/30 | 日証協 | 204,200株 | +1.39% | 5,000株 | +51.52% | 135,172株 | -10.41% | 9,100株 | -3.19% |
2015/12/25 | 日証協 | 201,400株 | -39.08% | 3,300株 | -96.47% | 150,873株 | -37% | 9,400株 | -21.73% |
2015/12/18 | 日証協 | 330,600株 | -3.22% | 93,500株 | +1163.51% | 239,473株 | -1.56% | 12,010株 | +93.71% |
※株式分割は考慮していませんのでご注意ください。
Page Top